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SUMMARY 
Phosphatidylcholine, which is required for fatty acid, hydrocarbon and drug 
hydroxylation in a reconstituted liver microsomal enzyme system, is essential for the 
enzymatic reduction of cytochrome P-450. 
The enzyme system in liver microsomes which catalyzes the hydroxylation of fatty 
acids, hydrocarbons and a variety of drugs and other foreign compounds has been resolved 
into 3 components. These are: (a) a solubilized form of cytochrome P-450, (b) a solubilized 
form of NADPH-cytochrome P-450 reductase, and (c) a heat-stable component which has 
the solubility properties of a lipid. All 3 components were found to be essential for the 
hydroxylation of hydrocarbons (e.g. octane and cyclohexane) and drugs (e.g. benzphetamine, 
hexobarbital and ethylmorphine) as well as fatty acids 1-3 . 
We have recently fractionated the microsomal lipid by column chromatography on 
silicic acid and by preparative thin-layer chromatography and identified the active 
component as phosphatidylcholine. Neither a neutral lipid fraction nor phosphatidyl- 
ethanolamine could substitute for the active lipid, and phosphatidylethanolamine proved to 
be inhibitory when added to the enzyme system along with phosphatidylcholine. The active 
lipid neither caused spectral changes when added to cytochrome P-450, nor did it alter the 
binding of substrates such as laurate or benzphetamine to cytochrome P-450. A number of 
synthetically prepared phosphatidylcholines were tested for their ability to replace the 
microsomal lipids. Those having unsaturated or short-chain fatty acid residues, such as 
dioleoyl- and mono- and di-lauroylphosphatidylcholine, were highly effective. Dioleoyl- 
phosphatidylcholine, for example, was if anything more active than the microsomal lipid 
component in effecting the hydroxylation of benzphetamine, ethylmorphine, hexane, 
octane and laurate, and was fully active in electron transfer as judged by the reduction of 
the cytochrome P-450-carbon monoxide complex under anaerobic conditions 4. 
Evidence has now been obtained that the lipid is essential for electron transfer to 
cytochrome P-450. When NADPH was incubated with cytochrome P-450 in the presence of 
the reductase and carbon monoxide (free of oxygen), extensive reduction, indicated by the 
peak at 450 rn~, was seen only when the lipid was present. Since the reaction was too rapid 
for the initial rate to be measured by conventional spectrometry, stopped-flow measurements 
were carried out in a Gibson-Milnes apparatus. In accord with the findings of others using 
intact liver microsomes s-7, biphasic kinetics was observed. The rapid phase was mostly 
completed in less than one second. The first-order-rate constants which were determined are 
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given in Table I. It may be noted that the constant for the rapid phase was clearly in excess 
of the turnover number of the enzyme, which is 22 min-1 (moles of benzphetamine 
hydroxylated per mole of cytochrome P-450) at 25 °. Of particular interest, when the lipid 
component was omitted, the rapid phase of the reaction could not be seen by the stopped- 
flow technique. On the other hand, in contrast to results reported by others for microsomes, 
the presence of substrate (benzphetarnine or octane) does not enhance the rate of electron 
transfer from NADPH to cytochrome P-450. These findings clearly establish a role for the 
lipid in the electron transfer step. Although this function of the lipid accounts for its role 
in substrate hydroxylation, an additional function (e.g. at the stage of the reaction at which 
oxygen is inserted) cannot be ruled out at this time. 
TABLE I 
KINETICS OF CYTOCHROME P-450 REDUCTION AS DETERMINED 
BY STOPPED-FLOW SPECTROMETRY 
Components added to First-order-rate constants 
NADPH-reductase-P-450 system 
Rapid ~hase Slow phase 
Lipid Substrate (min-X ) (min--l ) 
Microsomal Benzphetamine 100 6 
Microsomal Octane 82 1 
Microsomal None 99 4 
None Benzphetamine (absent) < 1 
None None (absent) < 1 
In other experiments the stoichiometry of drug hydroxylation has been studied by 
determination of NADPH disappearance, O= uptake, and product formation from 
benzphetamine and has been shown to correspond to the following equation: 
R2NCH3 + NADPH + H + + 02 --' R2NH + CH20 + NADP ÷ + H20 
These results were obtained, however, only when a trace of catalase was added to the 
reaction mixture s . In the absence of catalase the oxygen uptake was high, but only in the 
complete reaction mixture containing substrate. That an oxygen-containing compound 
actually accumulates was shown in experiments in which the catalase was added at the end 
of 5 min, and oxygen uptake was then restored to normal after an initial liberation of oxygen. 
Several lines of evidence suggest that the intermediate acted on by eatalase is not hydrogen 
peroxide, but the significance of these findings with respect to the generation of an 
"activated oxygen" which attacks and hydroxylates the various substrates remains to be 
established. 
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